PND18 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS OTHER DISEASE MODYFING THERAPIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN GERMANY
May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.1291
https://www.valueinhealthjournal.com/article/S1098-3015(19)31483-4/fulltext
Section Title :
Section Order :
10798
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31483-4&doi=10.1016/j.jval.2019.04.1291